| Literature DB >> 34510005 |
Jarle Jakobsen1,2, Marit B Veierød2, Tom K Grimsrud3, Sophie Dorothea Fosså4,5, Bato Hammarström6, Kristina Kjærheim3.
Abstract
OBJECTIVES: To examine age at diagnosis, prognostic factors and survival of prostate cancer (PCa) in Norwegian firefighters and three other occupations undergoing occupational health check-ups, and comparing with PCa cases in the general population.Entities:
Keywords: firefighters; medical oncology; military personnel; occupational health services; urogenital system
Mesh:
Substances:
Year: 2021 PMID: 34510005 PMCID: PMC8862087 DOI: 10.1136/oemed-2021-107622
Source DB: PubMed Journal: Occup Environ Med ISSN: 1351-0711 Impact factor: 4.402
Characteristics of prostate cancer cases diagnosed in Norway 1960–2017
| Firefighters | Reference occupations* n=4734 | General population | |
| Age at diagnosis, years | |||
| Mean (SD) | 67.5 (9.2) | 66.7 (8.6) | 71.0 (8.7) |
| Range | 44–93 | 41–94 | 24–100 |
| Period of diagnosis, n (%) | |||
| 1960–1993 | 77 (16) | 447 (10) | 33 860 (30) |
| 1994–2006 | 135 (28) | 1202 (25) | 35 211 (31) |
| 2007–2017 | 275 (56) | 3085 (65) | 44 062 (39) |
| Region of residence, n (%) | |||
| Northern Norway | 61 (13) | 464 (10) | 10 066 (9) |
| Central Norway | 44 (9) | 434 (9) | 10 056 (9) |
| Western Norway | 137 (28) | 1 055 (22) | 31 324 (28) |
| Southern Norway | 29 (6) | 316 (7) | 7195 (6) |
| Eastern Norway | 216 (44) | 2453 (52) | 54 218 (48) |
| Missing | 0 (0) | 12 (<1) | 274 (<1) |
| Marital status, n (%) | |||
| Unmarried | 22 (5) | 192 (4) | 8098 (7) |
| Married | 367 (75) | 3518 (74) | 75 130 (67) |
| Widower/divorced/separated | 84 (17) | 908 (19) | 21 762 (19) |
| Missing | 14 (3) | 116 (3) | 8143 (7) |
*Military employees, pilots and police officers.
Mean age (95% CI) at diagnosis of prostate cancer in Norway during 1960–2017, by period of diagnosis
| Firefighters | Reference occupations* n=4734 | General population | |
| Mean age (95% CI) | Mean age (95% CI) | Mean age (95% CI) | |
| Period of diagnosis | |||
| 1960–1993 | 70.4 (68.8 to 72.1) | 69.4 (68.6 to 70.1) | 72.5 (72.4 to 72.6) |
| 1994–2006 | 70.5 (68.9 to 72.0) | 67.5 (67.0 to 68.1) | 71.6 (71.5 to 71.7) |
| 2007–2017 | 65.1 (64.1 to 66.2) | 66.0 (65.7 to 66.3) | 69.4 (69.4 to 69.5) |
*Military employees, pilots and police officers.
Prognostic factors at diagnosis of prostate cancer in Norway in 1960–2017, by period of diagnosis
| Firefighters | Reference occupations* | General population | |
| Proportion (95% CI) | Proportion (95% CI) | Proportion (95% CI) | |
| Clinical stage | |||
| 1960–1993 | n=77 | n=447 | n=33 860 |
| Local | 0.71 (0.60 to 0.80) | 0.62 (0.57 to 0.66) | 0.69 (0.68 to 0.69) |
| Regional | 0.03 (<0.01 to 0.10) | 0.07 (0.05 to 0.09) | 0.05 (0.04 to 0.05) |
| Distant | 0.19 (0.12 to 0.30) | 0.22 (0.19 to 0.26) | 0.20 (0.20 to 0.21) |
| Missing | 0.07 | 0.09 | 0.06 |
| p-Value† | 0.24 | 0.7 | |
| 1994–2006 | n=135 | n=1202 | n=35 211 |
| Local | 0.63 (0.55 to 0.71) | 0.58 (0.55 to 0.60) | 0.54 (0.54 to 0.55) |
| Regional | 0.21 (0.15 to 0.28) | 0.21 (0.19 to 0.24) | 0.19 (0.19 to 0.19) |
| Distant | 0.08 (0.05 to 0.14) | 0.11 (0.10 to 0.13) | 0.14 (0.14 to 0.15) |
| Missing | 0.08 | 0.1 | 0.13 |
| p-Value† | 0.44 | 0.08 | |
| 2007–2017 | n=275 | n=3085 | n=44 062 |
| Local | 0.61 (0.55 to 0.66) | 0.61 (0.59 to 0.62) | 0.58 (0.57 to 0.58) |
| Regional | 0.28 (0.23 to 0.33) | 0.26 (0.24 to 0.27) | 0.26 (0.25 to 0.26) |
| Distant | 0.04 (0.02 to 0.07) | 0.06 (0.06 to 0.07) | 0.08 (0.08 to 0.08) |
| Missing | 0.07 | 0.07 | 0.08 |
| p-Value† | 0.26 | 0.04 | |
| 2004–2017 | n=333 | n=3508 | n=54 367 |
| PSA, ng/mL | |||
| <5.0 | 0.15 (0.12 to 0.19) | 0.12 (0.11 to 0.13) | 0.09 (0.09 to 0.10) |
| 5.0–9.9 | 0.37 (0.32 to 0.42) | 0.35 (0.34 to 0.37) | 0.30 (0.30 to 0.31) |
| 10.0–19.9 | 0.19 (0.15 to 0.23) | 0.21 (0.19 to 0.22) | 0.22 (0.21 to 0.22) |
| >19.9 | 0.17 (0.13 to 0.21) | 0.18 (0.17 to 0.20) | 0.25 (0.25 to 0.26) |
| Missing | 0.12 | 0.14 | 0.14 |
| p-Value† | 0.36 | <0.001 | |
| Gleason score | |||
| <7 | 0.36 (0.31 to 0.41) | 0.34 (0.33 to 0.36) | 0.30 (0.30 to 0.31) |
| 7 (3+4) | 0.26 (0.21 to 0.31) | 0.23 (0.22 to 0.25) | 0.23 (0.23 to 0.24) |
| 7 (4+3) | 0.12 (0.09 to 0.16) | 0.13 (0.12 to 0.14) | 0.15 (0.15 to 0.15) |
| 8 | 0.10 (0.07 to 0.13) | 0.13 (0.12 to 0.14) | 0.14 (0.14 to 0.14) |
| >8 | 0.07 (0.05 to 0.11) | 0.10 (0.09 to 0.11) | 0.12 (0.11 to 0.12) |
| Missing | 0.09 | 0.07 | 0.07 |
| p-Value† | 0.28 | 0.01 | |
| WHO performance status score | |||
| 0–1 | 0.70 (0.65 to 0.75) | 0.69 (0.67 to 0.70) | 0.63 (0.62 to 0.63) |
| >2 | 0.14 (0.11 to 0.18) | 0.13 (0.12 to 0.15) | 0.20 (0.20 to 0.21) |
| Missing | 0.16 | 0.18 | 0.17 |
| p-Value† | 0.96 | 0.002 |
*Military employees, pilots and police officers.
†Chi-squared test comparing firefighters with the group in question.
PSA, prostate-specific antigen.
Figure 1(A) Kaplan-Meier curves of overall survival after PCa diagnosis in Norway, by period of diagnosis. (B) Cumulative mortality curves of PCa-specific deaths in Norway, by period of diagnosis. PCa cases diagnosed in Norway during 1960–2017, n=118 354 men. End of follow-up is 31 December 2018. *Military employees, pilots and police officers. PCa, prostate cancer.
HRs* and 95% CIs for risk of death from all causes and risk of death from PCa, by period of diagnosis for PCa cases diagnosed in Norway 1960–2017, crude and adjusted for age at diagnosis
| Death from all causes | Firefighters | Reference occupations† | General population |
| 1960–1993 | |||
| n | 77 | 437 | 33 120 |
| Person-years | 506 | 3260 | 199 988 |
| Deaths | 77 | 434 | 32 975 |
| HR (95% CI)‡ | 0.93 (0.74 to 1.16) | 0.80 (0.73 to 0.88) | Ref |
| HR (95% CI)§ | 0.95 (0.76 to 1.19) | 0.87 (0.80 to 0.96) | Ref |
| 1994–2006 | |||
| n | 135 | 1199 | 34 940 |
| Person-years | 1221 | 12 009 | 296 882 |
| Deaths | 92 | 777 | 27 014 |
| HR (95% CI)‡ | 0.83 (0.68 to 1.02) | 0.71 (0.66 to 0.77) | Ref |
| HR (95% CI)§ | 0.86 (0.70 to 1.05) | 0.91 (0.84 to 0.97) | Ref |
| 2007–2017 | |||
| n | 275 | 3081 | 43 938 |
| Person-years | 1395 | 15 874 | 229 531 |
| Deaths | 46 | 469 | 10 639 |
| HR (95% CI)‡ | 0.71 (0.53 to 0.95) | 0.64 (0.58 to 0.70) | Ref |
| HR (95% CI)§ | 1.03 (0.77 to 1.37) | 0.92 (0.84 to 1.01) | Ref |
| Death from PCa | |||
| 1960–1993 | |||
| n | 77 | 437 | 33 120 |
| Person-years | 506 | 3260 | 199 988 |
| Deaths | 40 | 260 | 17 559 |
| HR (95% CI)‡ | 0.90 (0.66 to 1.22) | 0.93 (0.83 to 1.06) | Ref |
| HR (95% CI)§ | 0.92 (0.67 to 1.25) | 0.98 (0.87 to 1.11) | Ref |
| 1994–2006 | |||
| n | 135 | 1199 | 34 940 |
| Person-years | 1221 | 12 009 | 296 882 |
| Deaths | 41 | 398 | 12 523 |
| HR (95% CI)‡ | 0.80 (0.59 to 1.08) | 0.80 (0.72 to 0.88) | Ref |
| HR (95% CI)§ | 0.82 (0.60 to 1.12) | 0.98 (0.89 to 1.08) | Ref |
| 2007–2017 | |||
| n | 275 | 3081 | 43 938 |
| Person-years | 1395 | 15 874 | 229 531 |
| Deaths | 20 | 185 | 3936 |
| HR (95% CI)‡ | 0.83 (0.53 to 1.29) | 0.68 (0.59 to 0.79) | Ref |
| HR (95% CI)§ | 1.18 (0.76 to 1.83) | 0.97 (0.84 to 1.13) | Ref |
*Cox regression with time since diagnosis as time scale. End of follow-up is 31 December 2018.
†Military employees, pilots and police officers.
‡Crude.
§Adjusted for age at diagnosis.
PCa, prostate cancer.